跌跌不休的艾美疫苗:5年半累亏近34亿元,营收一半用于营销

深圳商报·读创
Aug 24

8月23日晚间,港股艾美疫苗(06660)发布截至2026年6月30日止六个月的业绩。上半年实现收入3.51亿元,同比下降31.87%;母公司拥有者应占亏损为1.23亿元,同比下降6.32%。收入下降的主要原因包括国家增值税政策调整、行业舆情影响、市场竞争加剧以及采购周期变化。  财报显示,公司二类疫苗和一类疫苗收入均有所下滑。其中,一类疫苗销售收入为1299万元,较2025年的5588万元大幅...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10